Showing 161 - 180 results of 13,425 for search '(((( b largest decrease ) OR ( ((b large) OR (a large)) decrease ))) OR ( ai large decrease ))', query time: 0.85s Refine Results
  1. 161

    DataSheet_1_Identification and Assessment of Necroptosis-Related Genes in Clinical Prognosis and Immune Cells in Diffuse Large B-Cell Lymphoma.xlsx by Qikai Zhang (6905096)

    Published 2022
    “…Background<p>With the unveiling of new mechanisms and the advent of new drugs, the prognosis of diffuse large B-cell lymphoma (DLBCL) becomes promising, but some patients still progress to the relapse or refractory stage. …”
  2. 162

    DataSheet_2_Identification and Assessment of Necroptosis-Related Genes in Clinical Prognosis and Immune Cells in Diffuse Large B-Cell Lymphoma.docx by Qikai Zhang (6905096)

    Published 2022
    “…Background<p>With the unveiling of new mechanisms and the advent of new drugs, the prognosis of diffuse large B-cell lymphoma (DLBCL) becomes promising, but some patients still progress to the relapse or refractory stage. …”
  3. 163

    DataSheet_1_Exploring the molecular mechanisms and shared gene signatures between rheumatoid arthritis and diffuse large B cell lymphoma.xlsx by Haoguang Li (2829245)

    Published 2022
    “…<p>The relationship between rheumatoid arthritis (RA) and diffuse large B-cell lymphoma (DLBCL) is well characterized, but the molecular mechanisms underlying this association have not been clearly investigated. …”
  4. 164

    Table1_Multi-Scale Modeling Recapitulates the Effect of Genetic Alterations Associated With Diffuse Large B-Cell Lymphoma in the Germinal Center Dynamics.docx by Elena Merino Tejero (10102450)

    Published 2022
    “…Several transcription factors and signaling pathways that play a central role in the progression of the GC reaction and B-cell differentiation have been shown to play an oncogenic role in diffuse large B-cell lymphoma. …”
  5. 165
  6. 166

    Supplementary Material for: High-sensitivity Troponin I Measurement in a Large Contemporary Cohort: Implications for Clinical Care by Esau D. (20563829)

    Published 2025
    “…Our aim was to investigate the prevalence of elevated hsTnI in a large, contemporary Canadian cohort and describe the effect of comorbidities on hsTnI concentration. …”
  7. 167
  8. 168

    Table1_Case Report: Immune Microenvironment and Mutation Features in a Patient With Epstein–Barr Virus Positive Large B-Cell Lymphoma Secondary to Angioimmunoblastic T-Cell Lymphom... by Fen Zhang (608307)

    Published 2022
    “…Here, we describe the tumor microenvironment and mutation features of a patient with EBV + large B-cell lymphoma (LBCL) secondary to AITL. …”
  9. 169
  10. 170
  11. 171
  12. 172

    Pathway analysis of significantly changed proteins comparing large stones vs sand. by Jacob Rose (12981890)

    Published 2022
    “…<p>(A) Among downregulated pathways and proteins in large stones (<i>when comparing large stones vs sand</i>), RNA export, ribosomal binding and proteases are significantly decreased. …”
  13. 173
  14. 174
  15. 175
  16. 176
  17. 177
  18. 178
  19. 179

    Supplementary Material for: Dysregulated MDR1 by PRDM1/Blimp1 Is Involved in the Doxorubicin Resistance of Non-Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma by Qing K. (11765465)

    Published 2021
    “…<b><i>Introduction:</i></b> The chemoresistance mechanism of diffuse large B-cell lymphoma (DLBCL) is still poorly understood, and patient prognosis remains unsatisfactory. …”
  20. 180